ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients Receiving Stable Opioid Substitution Treatment: Pooled Analysis of Efficacy and Safety in Phase 2 and Phase 3 Trials
dc.contributor.author | Puoti, M | en_US |
dc.contributor.author | Cooper, C | en_US |
dc.contributor.author | Sulkowski, MS | en_US |
dc.contributor.author | Foster, GR | en_US |
dc.contributor.author | Berg, T | en_US |
dc.contributor.author | Villa, E | en_US |
dc.contributor.author | Rodriguez-Perez, F | en_US |
dc.contributor.author | Rustgi, V | en_US |
dc.contributor.author | Wyles, DL | en_US |
dc.contributor.author | King, M | en_US |
dc.contributor.author | McGovern, BH | en_US |
dc.contributor.author | Wedemeyer, H | en_US |
dc.date.accessioned | 2015-03-26T08:38:31Z | |
dc.date.issued | 2014 | en_US |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/7068 | |
dc.format.extent | 1135A - 1136A | en_US |
dc.title | ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients Receiving Stable Opioid Substitution Treatment: Pooled Analysis of Efficacy and Safety in Phase 2 and Phase 3 Trials | en_US |
dc.type | Conference Proceeding | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483805013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 60 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Centre for Immunobiology [1121]